Trial Profile
An Abiraterone Acetate Plus Prednisone Drug-Drug Interaction Study With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Prednisone (Primary) ; Dextromethorphan; Theophylline
- Indications Prostate cancer
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 06 Apr 2012 Planned end date changed from 1 Mar 2011 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 01 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.